NEW YORK, Oct. 16, 2017 -- Greystone, a real estate lending, investment and advisory company, today announced it has launched a CMBS mezzanine loan platform to complement its existing CMBS platform. The new mezzanine loan product is intended to accompany a newly-originated CMBS first mortgage loan from Greystone.
Terms for Greystone CMBS mezzanine loans include:
- Loan size of $500,000 to $5 million
- 5- and 10-year terms; same as first mortgage
- 75-85% LTV
- Interest-only, or consistent with senior mortgage loan
- 12-15% coupon varying with LTV, DSCR, market and sponsor
- Non-recourse
“This mezzanine loan product meets a need for capital that is overlooked by traditional providers of mezzanine financing due to the smaller size – yet it’s still a critical component of the capital stack,” said Rob Russell, Head of CMBS Production at Greystone. “Combining the flexibility of CMBS with Greystone’s capabilities to execute mezzanine financing for our clients make this a game-changing loan product.”
About Greystone
Greystone is a real estate lending, investment and advisory company with an established reputation as a leader in multifamily and healthcare finance, having ranked as a top FHA and Fannie Mae lender in these sectors. Our range of services includes commercial lending across a variety of platforms such as Fannie Mae, Freddie Mac, CMBS, FHA, USDA, bridge and proprietary loan products. Loans are offered through Greystone Servicing Corporation, Inc., Greystone Funding Corporation and/or other Greystone affiliates. For more information, visit www.greyco.com.
PRESS CONTACT:
Karen Marotta
Greystone
212-896-9149
[email protected]


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 



